Intelligence

#ADME / Tox #Analysis #Analytical chemistry #Automation / robotics #Business #Chemical engineering #Chemistry #Clinical trials #Drug development #Drug discovery #Gene therapy #High throughput screening #Lead discovery #Regulatory #RNA #Screening #Therapeutics

Seeing is Believing: The Benefits of Visual Analysis in Research

Seeing is Believing: The Benefits of Visual Analysis in Research By Dr Christopher Ahlberg There is a growing pressure in todays climate for pharmaceutical companies to find tomorrows wonder drugs and dominate the major market segments. Recently, they have also been under attack for poor research productivity, for… Read More

#Archive

#ADME / Tox #AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Biochemistry #Business #Cellular & Molecular biology #Cellular assays #Chemistry #Clinical specialities #Clinical trials #Combinatorial chemistry #Computational chemistry #Drug development #Drug discovery #Drug targets #Enabling technologies #Genomics #High Content Screening #High throughput screening #In Silico Biology #Lead discovery #Lead optimisation #Medicinal chemistry #Organic chemistry #Patent Law #PCR #Pharmacology #Pharmokinetics #Preclinical #RNA #Screening #Toxicology

Medicinal Chemistry: Progress through innovation

Medicinal Chemistry: Progress through innovation By Dr Terry Hart Medicinal chemistry is a specialised science that has evolved to encompass a broad range of disciplines concerned with the identification, synthesis and development of drug-like compounds for therapeutic use. It needs a wide range of expertise, developed through years… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Animal models #Assay development optimisation & technology #Automation / robotics #Business #Cell therapy #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Drug development #Drug discovery #Drug targets #Enabling technologies #Gene therapy #Genetics / genomes #High throughput screening #Lead discovery #Medicinal chemistry #Patent Law #Pharmacology #Pharmokinetics #Preclinical #Protein chemistry / Proteomics #RNA #Screening #Stem cells #System biology #Systems biology #Target validation #Therapeutics

Ion Channel Drug Targets: Unlocking the potential

Ion Channel Drug Targets: Unlocking the potential By Dr Dayle S. Hogg, Dr Philip Boden, Dr Geoff Lawton and Dr Roland Z. Kozlowski A striking number of drugs targeting ion channels have reached blockbuster status, generating $ billion revenues. In spite of the historical success of ion channels… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Biochemistry #Cellular & Molecular biology #Cellular assays #Chemistry #Combinatorial chemistry #Drug development #Drug discovery #Drug targets #Genetics / genomes #Genomics #High Content Screening #High throughput screening #Imaging #Immunology #Lead discovery #Mass spectrometry / NMR #RNA #Screening #Sequencing #Stem cells #System biology #Systems biology #Target validation

Miniaturisation of Assay Development and Screening

Miniaturisation of Assay Development and Screening By Andreas Boettcher and Dr Lorenz M. Mayr In recent years we have seen a strong increase in the number of chemical compounds and molecular targets used for lead discovery by high-throughput screening among most Pharma and Biotech companies. This has caused… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Cell culture #Cellular assays #Chemistry #Clinical specialities #Clinical trials #Drug development #Drug discovery #Immunology #Lead discovery #Pharmokinetics #Preclinical #Protein chemistry / Proteomics #Regulatory #RNA #Screening #Stem cells #Therapeutics

Immunogenicity of Therapeutic Proteins

Immunogenicity of Therapeutic Proteins By Dr Ivo Van Walle, Dr Ignace Lasters and Philippe Stas Therapeutic proteins enter the market in increasing numbers, and current observations confirm that most of these biopharmaceuticals are to a variable extent immunogenic. This may compromise the efficacy,… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Assay development optimisation & technology #Biochemistry #Business #Cell culture #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Drug development #Drug discovery #Drug targets #High Content Screening #High throughput screening #Imaging #Lead discovery #Lead optimisation #Microbiology #Microfluidics #Organic chemistry #PCR #Pharmokinetics #Protein chemistry / Proteomics #RNA #Screening #Stem cells #System biology #Systems biology #Toxicology

Current Biosensor Technologies in Drug Discovery

Current Biosensor Technologies in Drug Discovery By Dr Matthew A. Cooper Over the past two decades the benefits of biosensor analysis have begun to make an impact in the market, and systems are beginning to be used as mainstream research tools in many laboratories. Biosensors are… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Business #Cell culture #Cellular & Molecular biology #Cellular assays #Drug development #Drug discovery #Drug targets #Enabling technologies #Genetics / genomes #High Content Screening #High throughput screening #Imaging #Lead discovery #Lead optimisation #PCR #Pharmokinetics #RNA #Screening #Stem cells #System biology #Systems biology #Target validation #Toxicology

Changing Dynamics in Dispense and Imaging Assays

Changing Dynamics in Dispense and Imaging Assays By Dr John Comley The prospects for a significant shift in dispense and imaging (D&I) assays towards a greater utilisation of calcium-mediated flash luminescence readouts appears to be finally under way. Driving this changing dynamic is the acceptance that… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Animal models #Automation / robotics #Business #Cell culture #Cell therapy #Chemical engineering #Chemistry #Clinical trials #Drug development #Drug discovery #Drug targets #Gene therapy #Genetics #Genetics / genomes #Genomics #High Content Screening #High throughput screening #Immunology #Lead discovery #Patent Law #RNA #Screening #Sequencing #Stem cells #System biology #Systems biology #Therapeutics

The Timetable of Invention and it’s Relevance to Drug Discovery

The Timetable of Invention and it’s Relevance to Drug Discovery By Dr William Bains The most critical question to any investor in new technology should not be whether a technology will work. Technologies nearly always work in the end, providing they do not break fundamental laws of physics,… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Animal models #Biochemistry #Business #Chemical engineering #Chemistry #Drug development #Drug discovery #Drug targets #Gene therapy #Genomics #Lead discovery #Molecular medicine #Organic chemistry #Orphan drugs #Protein chemistry / Proteomics #RNA #System biology #Systems biology #Therapeutics

Whither Pharma? The demise of pharma’s blockbuster business model

By Dr Alpheus Bingham It has been suggested that the blockbuster business model, which has been the key to big pharma success, is now broken and completely beyond repair. In a truly global and fast changing business world, is it time to examine alternatives to the… Read More

#Archive

#Academic #Analytical chemistry #Automation / robotics #Chemical engineering #Chemistry #Combinatorial chemistry #Drug development #Drug discovery #Enabling technologies #High throughput screening #Lead discovery #Lead optimisation #Medicinal chemistry #Molecular medicine #Organic chemistry #Pharmokinetics #Preclinical #Protein chemistry / Proteomics #RNA #Screening

Microwave-assisted synthesis in the pharmaceutical industry a current perspective and future prospects

Microwave-assisted synthesis in the pharmaceutical industry a current perspective and future prospects By Dr Richard Wagner In the past five years there has been a dramatic upsurge in the use of microwave heating within the pharmaceutical industry to facilitate the chemical synthesis of new chemical entities. The… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Animal models #Biochemistry #Cell / tissue culture #Cell culture #Cell therapy #Cellular & Molecular biology #Clinical specialities #Clinical trials #Drug development #Drug discovery #Drug targets #Gene therapy #Genetics / genomes #Genomics #Immunology #Lead discovery #Molecular medicine #Oncology #Preclinical #Protein chemistry / Proteomics #RNA #Stem cells #Target validation #Therapeutics

Silence For Health – Development of RNA interference based cancer therapy

Silence For Health – Development of RNA interference based cancer therapy By Dr Ansgar Santel RNA interference (RNAi) has become an invaluable tool for biomedical research. It is already routinely used as an indispensable approach for gene function analysis in basic biological research and for target identification as… Read More

#Archive

#ADME / Tox #AI / data analytics / healthtech / informatics #Analysis #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Business #Cellular assays #Chemical engineering #Clinical specialities #Drug development #Drug discovery #Drug targets #High Content Screening #High throughput screening #Lead discovery #Microfluidics #RNA #Screening #Stem cells #Target validation #Toxicology

Advances in laboratory automation for drug discovery

Advances in laboratory automation for drug discovery By Charanya Ramachandran Laboratory automation has metamorphosed the realm of drug discovery over the years through two of major influential factors – cost benefit and error reduction. Automation has reframed the traditional drug discovery process by making feasible… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Cellular & Molecular biology #Clinical trials #Drug development #Drug discovery #Drug targets #Imaging #RNA #Stem cells #Toxicology

PLAYING WITH TIME – Digital imaging comes of age

PLAYING WITH TIME – Digital imaging comes of age By Dr Pam Pickering Seeing dynamic intra- and extra-cellular events as they happen is central to revealing the mechanisms of disease, identifying key targets for drug intervention and assessing the impact of drug treatment on living cells. Interpreting these… Read More

#Archive

#Analysis #Analytical chemistry #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Biomarkers #Business #Cell therapy #Cellular assays #Chemistry #Clinical specialities #Clinical trials #Combinatorial chemistry #Drug development #Drug discovery #Drug targets #Gene therapy #Genetics / genomics #Genomics #High Content Screening #High throughput screening #Imaging #Lead discovery #Mass spectrometry / NMR #Microfluidics #Molecular medicine #Nanomedicine / nanotechnology #Organic chemistry #Precision medicine #Protein chemistry / Proteomics #Regulatory #RNA #Screening #Stem cells #Target validation #Therapeutics #Toxicology

The Role of Nanotechnology in Drug Discovery

By Dr Amarpreet S Dhiman In terms of drug discovery and development, the role of nanotechnology currently lies in improving diagnostic methods, developing improved drug formulations and drug delivery systems for disease therapy. The breakthrough format of nanotechnology offers innovative solutions, giving researchers greater… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Biochemistry #Business #Cellular & Molecular biology #Cellular assays #Chemistry #Clinical specialities #Drug development #Drug discovery #Drug targets #Enabling technologies #High Content Screening #High throughput screening #Immunology #Organic chemistry #PCR #Protein chemistry / Proteomics #RNA #Screening #Stem cells #Target validation #Therapeutics #Urinary

TR-FRET Based Assays – Getting better with age

TR-FRET Based Assays – Getting better with age By Dr John Comley Despite having been available for nearly 15 years, TR-FRET based assays are still the preferred fluorescent assay format for many screeners. A recent survey ranked Cisbio’s TR-FRET product (HTRF) as the most frequently used generic… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Animal models #Assay development optimisation & technology #Biomarkers #Cell therapy #Chemistry #Clinical specialities #Clinical trials #Combinatorial chemistry #Drug development #Drug discovery #Drug targets #Gene therapy #Genetics / genomes #Genetics / genomics #Genomics #High Content Screening #High throughput screening #Imaging #Immunology #Lead discovery #Molecular medicine #Oncology #Pharmacogenomics #Preclinical #Protein chemistry / Proteomics #Regulatory #RNA #Screening #Stem cells #System biology #Target validation #Toxicology #Translational #Translational chemistry

Understanding the strategic importance of BIOMARKERS for the discovery and early development phases

Share Share Tweet Email Understanding the strategic importance of BIOMARKERS for the discovery and early development phases Understanding the strategic importance of BIOMARKERS for the discovery and early development phases By Dr Orest Hurko… Read More

#Archive